PhotoPharmics https://photopharmics.com/ A New Therapy for Neurodegenerative Diseases Fri, 18 Apr 2025 16:05:41 +0000 en-US hourly 1 https://wordpress.org/?v=6.7.2 https://photopharmics.com/wp-content/uploads/2017/04/cropped-icon-32x32.png PhotoPharmics https://photopharmics.com/ 32 32 PhotoPharmics Closes Oversubscribed $6 Million Series B Extension to Advance FDA Breakthrough Parkinson’s Device https://photopharmics.com/photopharmics-closes-oversubscribed-6-million-series-b-extension-to-advance-fda-breakthrough-parkinsons-device/ Fri, 18 Apr 2025 15:43:26 +0000 https://photopharmics.com/?p=6086 Original Press Release Funding supports key milestones as the Pivotal, Phase 3 trial surpasses 200 enrolled participants SALT LAKE CITY – PhotoPharmics, a leader in specialized light therapy for neurodegenerative diseases, today announced the close of its oversubscribed $6 million Series B extension. The round was led by Kickstart Fund with participation from current and […]

The post PhotoPharmics Closes Oversubscribed $6 Million Series B Extension to Advance FDA Breakthrough Parkinson’s Device appeared first on PhotoPharmics.

]]> PhotoPharmics Reaches 200 Participants in Landmark Light for PD Clinical Trial https://photopharmics.com/photopharmics-reaches-200-participants-in-landmark-light-for-pd-clinical-trial/ Mon, 07 Apr 2025 21:13:21 +0000 https://photopharmics.com/?p=5898 Two-thirds enrolled in one of the largest remote Parkinson’s trials—redefining access and inclusion in therapeutic research Salt Lake City, Utah – PhotoPharmics announced today that its Pivotal, Phase 3 clinical trial, Light for PD™, has now reached 200 participants—marking two-thirds of its target enrollment. This milestone positions the study as one of the largest remote […]

The post PhotoPharmics Reaches 200 Participants in Landmark Light for PD Clinical Trial appeared first on PhotoPharmics.

]]> 10 Ways to Manage Your Parkinson’s Symptoms https://photopharmics.com/10-ways-to-manage-your-parkinsons-symptoms-and-enhance-your-life/ Mon, 31 Mar 2025 17:24:34 +0000 https://photopharmics.com/?p=5882 By actively incorporating regular exercise, a balanced diet, mental health strategies, quality sleep habits, social engagement, mindfulness, effective medication management, environmental adaptations, cognitive stimulation, and exploring complementary therapies, individuals living with Parkinson's can take a proactive role in managing their symptoms, maintaining their independence, and enhancing their overall quality of life.

The post 10 Ways to Manage Your Parkinson’s Symptoms appeared first on PhotoPharmics.

]]> Available Diagnosis and Treatment for Parkinson’s https://photopharmics.com/available-diagnosis-and-treatment-for-parkinsons/ Fri, 28 Feb 2025 20:11:55 +0000 https://photopharmics.com/?p=5872 Introduction Parkinson’s is one of the most common neurodegenerative disorders, second only to Alzheimer’s. Globally, it affects around 1% of people over 60, making it the leading movement-related neurological condition. “Parkinson’s diagnosis and treatment options” is one of the most common concerns for individuals living with Parkinson’s and their families. The uncertainty surrounding symptoms, medical […]

The post Available Diagnosis and Treatment for Parkinson’s appeared first on PhotoPharmics.

]]> PhotoPharmics Announces Leadership Transition in Clinical & Scientific Advisory Board https://photopharmics.com/photopharmics-announces-leadership-transition-in-clinical-scientific-advisory-board/ Fri, 31 Jan 2025 17:00:00 +0000 https://photopharmics.com/?p=5846 PhotoPharmics, a pioneer in specialized phototherapy for neurodegenerative diseases, today announced the appointment of Robert A. Hauser, MD, MBA, as the new Chairman of its Clinical & Scientific Advisory Board (CSAB). Dr. Hauser assumes this leadership role following the recent passing of Warren Olanow, MD, FRCPC, a visionary in the field of Parkinson’s disease research […]

The post PhotoPharmics Announces Leadership Transition in Clinical & Scientific Advisory Board appeared first on PhotoPharmics.

]]> Understanding the Types of Parkinsonism https://photopharmics.com/understanding-the-types-of-parkinsonism/ Mon, 27 Jan 2025 18:54:09 +0000 https://photopharmics.com/?p=5809 This article explains Parkinsonism, a group of conditions mimicking Parkinson's disease, detailing its various types, including primary (like PD and atypical forms) and secondary causes. It also discusses diagnosis, the importance of neurological evaluation, and emerging therapies for managing symptoms.

The post Understanding the Types of Parkinsonism appeared first on PhotoPharmics.

]]> Parkinson’s Iceberg: The Non-Motor Symptoms You Don’t See https://photopharmics.com/non-motor-symptoms-of-parkinsons/ Fri, 20 Dec 2024 16:39:19 +0000 https://photopharmics.com/?p=5786 Introduction “My father experienced hallucinations and delusions, and at the time, we didn’t realize these symptoms were part of his Parkinson’s disease. My mom tried to shield my family and carry the burden alone each day. I wish l’d known there was more to Parkinson’s than motor symptoms, which is why l’m encouraging people and […]

The post Parkinson’s Iceberg: The Non-Motor Symptoms You Don’t See appeared first on PhotoPharmics.

]]> An Overview of Parkinson’s Disease https://photopharmics.com/an-overview-of-parkinsons-disease/ Thu, 05 Dec 2024 18:52:43 +0000 https://photopharmics.com/?p=5751 What is Parkinson’s? Parkinson’s Disease (PD) is a complex neurodegenerative disorder that affects the nervous system and progressively worsens over time.  While motor symptoms—such as tremors, stiffness, and slow movement—are often the most observable and commonly associated with the condition, Parkinson’s encompasses a broader spectrum of challenges.  Non-motor symptoms (NMS), including anxiety, depression, apathy, and […]

The post An Overview of Parkinson’s Disease appeared first on PhotoPharmics.

]]> PhotoPharmics to Present Patient Interest Findings from Groundbreaking Remote Parkinson’s Trial at PSG Annual Meeting https://photopharmics.com/photopharmics-to-present-patient-interest-findings-from-groundbreaking-remote-parkinsons-trial-at-psg-annual-meeting/ Thu, 05 Dec 2024 16:00:25 +0000 https://photopharmics.com/?p=5769 Presentation to Highlight Feasibility and Interest in Decentralized Home-Based Phase 3 Trial Salt Lake City, Utah — December 5, 2024 — PhotoPharmics, a pioneer in non-invasive phototherapy for neurological disorders, today announced it will present a poster titled “An Entirely Remote, Home-based Phase 3 Clinical Trial of a Specialized Light Therapy Device for Parkinson’s Disease […]

The post PhotoPharmics to Present Patient Interest Findings from Groundbreaking Remote Parkinson’s Trial at PSG Annual Meeting appeared first on PhotoPharmics.

]]> PhotoPharmics Announces First Subject Completes FDA Pivotal Clinical Trial for the Celeste Device in Parkinson’s https://photopharmics.com/photopharmics-announces-first-subject-completes-fda-pivotal-clinical-trial-for-the-celeste-device-in-parkinsons/ Sun, 29 Sep 2024 12:18:51 +0000 https://photopharmics.com/?p=5713 PhotoPharmics, a leader in non-invasive phototherapy for neurological disorders, has reached a significant milestone in its ongoing FDA pivotal “Light for PD” trial for the Celeste therapeutic device. The first subject has successfully completed the full 6-month treatment course and clinical visits, marking an important step towards the successful completion of the trial and future FDA authorization of Celeste in treating Parkinson’s disease (PD).

The post PhotoPharmics Announces First Subject Completes FDA Pivotal Clinical Trial for the Celeste Device in Parkinson’s appeared first on PhotoPharmics.

]]>